INTRODUCTION AND OBJECTIVES: Anastomotic urethroplasty is an effective but occasionally controversial treatment for short bulbar urethral strictures. Non-transecting variations of anastomotic urethroplasty were created in part to address this controversy. The objective of this study is to assess current outcomes of anastomotic urethroplasty and compare outcomes of transecting and non-transecting techniques.
METHODS: 171 patients with complete follow-up underwent anastomotic bulbar urethroplasty from September 2003 to May 2016. Patient age, stricture length, location, etiology, 90-day complications and semi-quantitative assessment of sexual dysfunction were recorded. The primary (objective) outcome was success defined as urethral patency >16Fr on routine follow-up cystoscopy. Secondary outcome measures included 90-day complications (Clavien !2) and de novo sexual dysfunction assessed at 6 months. Statistical comparison between transecting and non-transecting cohorts was made using Cox Regression Analysis and Chi-square when appropriate. RESULTS: One hundred and thirty patients underwent transecting anastomotic urethroplasty while 41 had a non-transecting anastomotic urethroplasty. Mean stricture length was 1.5AE0.5cm (range 1-3) with a mean patient age of 43.0AE18.0 years. 78.9% of patients failed prior endoscopic treatment (135/171) and 2.4% failed prior urethroplasty (4). Overall there was a 98.2% (168/171) success rate with a mean follow-up of 74.9(AE46.7) months. 7.0% (12/171) of patients experienced a 90-day postoperative complication of Clavien !2 including 2.9% wound-related complications (5), 1.8% scrotal hematomas (3), 1.8% UTI (3), and 0.6% urethral bleeding (1). 9.9% reported an adverse change in sexual function including 6.4% erectile dysfunction (11), 1.8% ejaculatory dysfunction (3), 1.2% painful erection (2), and 0.6% chordee (1). When comparing transecting and non-transecting technique success using Cox Regression analysis there was no difference in urethroplasty success (97.7% vs. 100%; p¼0.63) and no difference in postoperative complications (7.7% vs. 4.9%; p¼0.73) but patients undergoing transecting anastomotic urethroplasty were more likely to report an adverse change in sexual function (13.1%; vs. 0%; p¼0.013).
CONCLUSIONS: Anastomotic urethroplasty remains a highly effective treatment for short-segment bulbar urethral strictures with relatively minimal associated morbidity. Newer non-transecting anastomotic urethroplasty techniques appear to compare favorably in the short-term and may reduce the risk of associated sexual dysfunction. We reviewed our experience with this procedure.
METHODS: Between January 2009 and December 2015, 125 men with a mean age of 42 (range 16-77) years have undergone a "non-transecting approach" to their bulbar urethral stricture. 112 patients had idiopathic strictures, 5 had iatrogenic strictures, 5 had urethral trauma, 5 were post-radical prostatectomy strictures and 3 were post-TURP strictures. In the same timeframe, 36 transecting anastomotic urethroplasties were performed for straddle injuries and 201 dorsal patch bulbar urethroplasty were performed for long urethral strictures. 58 patients had a non-transecting mucosal anastomotic repair, 48 patients had a non-transecting augmented urethroplasty using buccal graft and 19 underwent a Heineke-Mikulicz-type stricturoplasty alone. All patients underwent clinical assessment and flow rate studies and urethrograms prospectively.
RESULTS: Clinically, 116 patients (92.8%) were happy with the result of their surgery, 2 were unhappy (but had normal flow rates) and there were 4 failures, who all underwent revisional surgery. 3 patients were lost to follow-up. The mean post-operative peak flow rate was 34.9mls per second, in 102 patients. 7 patients had flow rates of less than 15mls per second, including the 4 failures, 3 patients voided less than 100mls and where therefore not assessable and 13 patients refused a flow rate study or were lost to follow-up (n¼3). On antegrade/ retrograde urethrogram, 120 were normal, 1 had a slightly reduced calibre but had a normal flow rate, there were 4 recurrent strictures and 9 refused or were lost to follow-up (n¼3). Overall 118 of 122 patients (96%) were a success clinically by radiology and flow rate study as well as subjectively.
CONCLUSIONS: The non-transecting approach to bulbar urethroplasty gives results that are at least as good as previously reported for excision and primary anastomosis or augmented anastomotic urethroplasty or dorsal patch urethroplasty. The increasingly widespread use of this procedure is therefore entirely justified.
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INTRODUCTION AND OBJECTIVES: Urethral stricture disease is seen in 2-9% of patients after transurethral resection of the prostate (TURP) but data is limited as to treatment outcomes. Our purpose is to establish patterns of disease severity and treatment for post-TURP stricture among 7 high volume centers.
METHODS: A retrospective database was created for patients who underwent management of post-TURP strictures at 7 reconstructive urology centers. Data consisted of demographics, TURP method, location/length of urethral strictures, interventions prior to urethroplasty, surgical technique used for urethroplasty, and outcomes. Exclusion criteria included age <18 and follow-up period <1 year. Success was defined as no need for intervention within the observation period. Data analysis was done from 7 institutions for a total of 130 patients. RESULTS: Mean age was 68 years (range 41-86). 77% of patients underwent monopolar TURP (n¼100). Other modalities reported were: 10% bipolar TURP (n¼13), 3% GreenLightTM laser (n¼4), 3% holmium laser (n¼4), 2% other lasers (n¼ 3) and 5% unknown modality (n¼6). Urethral stricture locations were: 29% bulbar urethra (n¼38), 17% membranous urethra (n¼22), 11% penile urethra (n¼15), 5% fossa navicularis urethra (n¼6), and 38% multiple locations (n¼49). The average intraoperative length of strictures was 4.4cm (range 1-23cm). Average number of endoscopic interventions prior to Vol. 197, No. 4S, Supplement, Sunday, May 14, 2017 THE JOURNAL OF UROLOGY â e657
